NYSE:OGEN

Oragenics Stock Predictions

Healthcare > Biotechnology

Buy OGEN

*Your capital is at risk

$0.610

+0 (+0%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

OGEN Prediction Chart

OGEN Predictions History

Latest community submissions for OGEN.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Nov 24, 2021	$0.509 -98.40%	$0.529	X	96.24%	1
AlexVel Pro	Nov 24, 2021	Bearish	$0.529	V	—	0
RamboRex3000 Pro	Jul 28, 2021	$0.798 -98.32%	$0.792	V	99.29%	4
JS Pro	Jul 28, 2021	$0.82 -98.28%	$0.792	V	96.64%	1
Kansasboy108	Jun 17, 2021	Bearish	$0.725	V	—	1
JS Pro	Apr 28, 2021	$0.786 -98.42%	$0.83	V	94.95%	0
archie H @archieH.199217	Apr 28, 2021	Bullish	$0.83	X	—	0
JS Pro	Mar 18, 2021	$1.09 -98.18%	$1.00	X	90.73%	0
Eric Simmons @EricSimmons.215770	Mar 18, 2021	Bearish	$1.00	V	—	1
JS Pro	Mar 10, 2021	$1.18 -98.14%	$1.06	V	88.68%	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for OGEN with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ORAGENICS INC

Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by